ConductScience.org, home

Paper4398381

Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.

Baker PJ and 3 others. J Immunol, 1971. Cited by 69 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells. Papers, record 4398381. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4398381

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.
PubMed
Journal
J Immunol
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2009-10-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baker PJP J
2Prescott BB
3Stashak PWP W
4Amsbaugh DFD F

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
AntigensMajor topic
Polysaccharides, BacterialMajor topic
Animals
Antibodies
Antibody-Producing Cells
Antigens, Bacterial
Hemolytic Plaque Technique
Immunization, Secondary
Immunoglobulin M
Mice
Spleen
Streptococcus pneumoniae

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
8531887Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Microbiol Rev1995https://conductscience.org/library/papers/8531887PubMed
6967453Influence of carrier-specific, thymus-derived cells on the immunologlobulin M antibody response to staphylococcal lipoteichoic acid.Infect Immun1980https://conductscience.org/library/papers/6967453PubMed
6193230Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide.J Exp Med1983https://conductscience.org/library/papers/6193230PubMed
4599880Selective roles of thymus-derived lymphocytes in the antibody response. II. Preferential suppression of high-affinity antibody-forming cells by carrier-primed suppressor T cells.J Exp Med1974https://conductscience.org/library/papers/4599880PubMed
4591177Lymphocyte proliferation in vitro induced by hapten autologous protein conjugates. I. A study on the class of lymphocytes responding in vitro and on the nature and specificity of their receptors.J Exp Med1974https://conductscience.org/library/papers/4591177PubMed
4571425
The primary and secondary antibody response to Escherichia coli O6 lipopolysaccharide analysed at the humoral and cellular level. Amount and avidity of the antibodies in relation to protective capacity.
Immunology1973https://conductscience.org/library/papers/4571425PubMed
4403476Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.J Exp Med1972https://conductscience.org/library/papers/4403476PubMed
4151455Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. II. Relationship between IgM immunoglobulin levels and the ability to give an IgM antibody response.J Exp Med1974https://conductscience.org/library/papers/4151455PubMed
4145387Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells.J Exp Med1973https://conductscience.org/library/papers/4145387PubMed
2972626Ability of monophosphoryl lipid A to augment the antibody response of young mice.Infect Immun1988https://conductscience.org/library/papers/2972626PubMed
2965680Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A.Infect Immun1988https://conductscience.org/library/papers/2965680PubMed
2783922Adjuvant effects of trehalose dimycolate on the antibody response to type III pneumococcal polysaccharide.Infect Immun1989https://conductscience.org/library/papers/2783922PubMed
2462536T-cell modulation of the antibody response to bacterial polysaccharide antigens.Infect Immun1989https://conductscience.org/library/papers/2462536PubMed
2143752Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides.Infect Immun1990https://conductscience.org/library/papers/2143752PubMed
1968433Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A.Infect Immun1990https://conductscience.org/library/papers/1968433PubMed
1855983Lipopolysaccharidelike immunological properties of cell wall glycoproteins isolated from Cytophaga johnsonae.Infect Immun1991https://conductscience.org/library/papers/1855983PubMed
1824762Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines.Infect Immun1991https://conductscience.org/library/papers/1824762PubMed
36442Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III.J Exp Med1979https://conductscience.org/library/papers/36442PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4398381

GET https://conductscience.org/api/papers/v1/4398381/authors